Proceedings of the GRAPPA 2016 Retreat.
Jadon DR., Gladman DD., Mease PJ., FitzGerald O., Chandran V., Goel N., Rosen CF., Maksymowych WP., Ritchlin CT., Ogdie A., Coates LC., Cauli A., Soriano ER., Husni ME., Campbell W., Azevedo VF., Callis Duffin K., Armstrong AW., Gottlieb AB., Kavanaugh A., Garg A., Helliwell PS.
In advance of its 2016 annual meeting, members of the steering committee of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) convened for a strategic planning meeting. The purpose of this advance meeting was to review the work of GRAPPA since its inception in 2003, ascertain and review the current priorities of the group, and devise a strategy for proceeding. The key accomplishments of GRAPPA to date, priorities and objectives for the next 5 years, and goals and opportunities for the GRAPPA committees were discussed. GRAPPA has a responsibility and commitment to patients, its members, and partners to innovate, inspire, and improve knowledge and the ability to care for people with psoriasis and psoriatic arthritis.